Literature DB >> 20068284

Primary pituitary lymphoma: idiopathic anasarca with relapse in bone marrow only.

Soley Bayraktar1, Wilfredo Bassini, Mark Goodman.   

Abstract

We report a case of primary large B cell-type pituitary lymphoma in a 47-year-old immunocompetent female who presented with headache and cranial nerve palsy. She was treated with the DeAngelis chemotherapy protocol and achieved a complete remission. At 1 and 6 months after completion of chemotherapy, she presented with anasarca and was diagnosed with relapse exclusively in the bone marrow twice. She received 8 cycles of R-CHOP chemotherapy and had complete resolution of anasarca. Consequently, we proceeded with salvage chemotherapy followed by autologous stem cell transplantation. To our knowledge, this is the first reported case of primary pituitary lymphoma that relapsed exclusively in the bone marrow and presented with clinical findings of idiopathic anasarca.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068284     DOI: 10.1159/000272920

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

Review 1.  Primary pituitary lymphoma: an update of the literature.

Authors:  A Tarabay; G Cossu; M Berhouma; M Levivier; R T Daniel; M Messerer
Journal:  J Neurooncol       Date:  2016-08-31       Impact factor: 4.130

2.  Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.

Authors:  Dong-Won Shin; Jeong Hoon Kim; Young-Hoon Kim; Young Hyun Cho; Seok Ho Hong
Journal:  J Neurooncol       Date:  2020-03-27       Impact factor: 4.130

3.  Primary lymphoma of the pituitary gland: an unusual cause of hemianopia in an immunocompetent patient.

Authors:  Pg Rainsbury; A Mitchell-Innes; Nj Clifton; Hs Khalil
Journal:  JRSM Short Rep       Date:  2012-08-17

4.  Primary Pituitary Lymphoma in Immunocompetent Patients: A Report on Two Case Studies and the Review of Literature.

Authors:  Lian Duan; Jie Liu; Yan Zhang; Lijia Cui; Xiao Zhai; Boju Pan; Lin Lu; Hui Pan; Yong Yao; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-04       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.